Vasopressin and oxytocin receptors in GtoPdb v.2023.1

  • Daniel Bichet University of North Carolina
  • Michel Bouvier Université de Montréal https://orcid.org/0000-0003-1128-0100
  • Bice Chini CNR Institute of Neuroscience
  • Gerald Gimpl Johannes Gutenberg-Universität
  • Gilles Guillon Institut de Génomique Fonctionnelle
  • Tadashi Kimura Osaka University
  • Mark Knepper National Institutes of Health
  • Stephen Lolait University of Bristol https://orcid.org/0000-0001-7228-8072
  • Maurice Manning University of Toledo College of Medicine
  • Bernard Mouillac Université de Montpellier https://orcid.org/0000-0002-3906-8673
  • Anne-Marie O'Carroll University of Bristol https://orcid.org/0000-0001-5255-8506
  • Claudine Serradeil-Le Gal VibeoSphen
  • Melvyn Soloff University of Texas
  • Joseph G. Verbalis Georgetown University Medical Center
  • Mark Wheatley University of Birmingham
  • Hans H. Zingg McGill University

Abstract


Vasopressin (AVP) and oxytocin (OT) receptors (nomenclature as recommended by NC-IUPHAR [94]) are activated by the endogenous cyclic nonapeptides vasopressin and oxytocin. These peptides are derived from precursors which also produce neurophysins (neurophysin I for oxytocin; neurophysin II for vasopressin). Vasopressin and oxytocin differ at only 2 amino acids (positions 3 and 8). There are metabolites of these neuropeptides that may be biologically active [69].

DOI: https://doi.org/10.2218/gtopdb/F66/2023.1
Published
26-Apr-2023
How to Cite
Bichet, D., Bouvier, M., Chini, B., Gimpl, G., Guillon, G., Kimura, T., Knepper, M., Lolait, S., Manning, M., Mouillac, B., O’Carroll, A.-M., Serradeil-Le Gal, C., Soloff, M., Verbalis, J. G., Wheatley, M. and Zingg, H. H. (2023) “Vasopressin and oxytocin receptors in GtoPdb v.2023.1”, IUPHAR/BPS Guide to Pharmacology CITE, 2023(1). doi: 10.2218/gtopdb/F66/2023.1.
Issue
Vol 2023 No 1 (2023)
Section
Summaries
Creative Commons License

This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.